Influence of X-ray spectrum and bowtie filter characterisation on the accuracy of Monte Carlo simulated organ doses: Validation in a whole-body CT scanning mode

•Different methodologies exist to model the X-ray spectrum and bowtie filter.•Simulated organ doses slightly depend on the applied CT characterisation model.•Depending on the used models, deviations in CT organ dose are within 6%•The X-ray spectrum model has a larger influence than the bowtie filter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physica medica 2024-11, Vol.127, p.104837, Article 104837
Hauptverfasser: Verfaillie, Gwenny, Rutten, Jeff, Dewulf, Lore, D’Asseler, Yves, Bacher, Klaus
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Different methodologies exist to model the X-ray spectrum and bowtie filter.•Simulated organ doses slightly depend on the applied CT characterisation model.•Depending on the used models, deviations in CT organ dose are within 6%•The X-ray spectrum model has a larger influence than the bowtie filter model.•Half-value layer and dose measurements provide sufficient input to model a CT. For patient-specific CT dosimetry, Monte Carlo dose simulations require an accurate description of the CT scanner. However, quantitative spectral information and information on the bowtie filter material and shape from the manufacturer is often not available. In this study, the influence of different X-ray spectra and bowtie filter characterisation methods on simulated CT organ doses is studied. Using ImpactMC, organ doses of whole-body CTs were simulated in twenty adult whole-body voxel models, generated from PET/CT examinations previously conducted in these patients. Simulated CT organ doses based on the manufacturer X-ray spectra and bowtie filter data were compared with those obtained using alternative characterisation models, including spectrum generators and experimentally measured dose data. A total of four different X-ray spectra and one bowtie filter model were defined based on these data. For all X-ray spectra and bowtie filter combinations, estimated CT organ doses are within 6% from those resulting from simulations with the CT characterisation models provided by the manufacturer. While varying the bowtie filter model results in CT organ dose differences smaller than 1%, dose differences up to 6% are observed when X-ray spectra are not based on the quantitative data from the manufacturer. Estimated organ doses slightly depend on the applied CT characterisation model. When manufacturer’s data are not available, half-value layer and dose measurements provide sufficient input to obtain equivalent X-ray spectra and bowtie filter profiles, respectively.
ISSN:1120-1797
1724-191X
1724-191X
DOI:10.1016/j.ejmp.2024.104837